Skip to main content
Clinical Trials/NCT00814398
NCT00814398TerminatedNot Applicable

Single Embryo Transfer Versus Double Embryo Transfer in Day 3 or Blastocyst Stage

IVI Sevilla2 sites in 1 country199 target enrollmentStarted: December 1, 2008Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Terminated
Sponsor
Enrollment
199
Locations
2
Primary Endpoint
Live-birth delivery rate

Study Overview

Brief Summary

The aim of this project is to study the best number (1 or 2)and day (3 vs 5)of embryo transfer in good prognosis patient.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
None

Eligibility Criteria

Ages
18 Years to 37 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Good prognosis IVF patients

Exclusion Criteria

  • Bad prognosis IVF patients

Outcomes

Primary Outcomes

Live-birth delivery rate

Time Frame: End of pregnancy (nine months after last transfer)

Secondary Outcomes

  • Acceptance of assigned randomised group(Day of randomisation)
  • Multiple live-birth rate(End of pregnancy (nine months after last transfer))

Investigators

Sponsor
IVI Sevilla
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Manuel Fernandez-Sanchez

Primary Investigator

IVI Sevilla

Study Sites (2)

Loading locations...

Similar Trials

Single Embryo Transfer Versus Double... | Clinical Trial